Keith Anthony Jones
CIK: 0002026411
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Humacyte, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 14, 2026HUMA
Humacyte, Inc.
Purchase(P)Direct10K shares at avg. $0.56$6K - Aug 20, 2026HUMA
Humacyte, Inc.
Purchase(P)Direct10K shares at avg. $0.69$7K - Aug 17, 2026HUMA
Humacyte, Inc.
Purchase(P)Direct30K shares at avg. $0.59$18K - Jun 11, 2026HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
80K shares- - Jun 12, 2025HUMA
Humacyte, Inc.
Award(A)DirectStock Options (right to buy)
80K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 | HUMA Humacyte, Inc. | Purchase(P) | 10,000 | $0.56 | $5,620 | Direct |
| Aug 20, 2026 | HUMA Humacyte, Inc. | Purchase(P) | 10,000 | $0.69 | $6,930 | Direct |
| Aug 17, 2026 | HUMA Humacyte, Inc. | Purchase(P) | 30,000 | $0.59 | $17,820 | Direct |
| Jun 11, 2026 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 80,000 | - | - | Direct |
| Jun 12, 2025 | HUMA Humacyte, Inc. | Award(A) Stock Options (right to buy) | 80,000 | - | - | Direct |
1-5 of 5 transactions
About Jones Keith Anthony
Jones Keith Anthony (SEC CIK 0002026411) files insider reports with the SEC as Director of Humacyte, Inc. (HUMA).
Signal8 holds 5 ownership filings by Jones Keith Anthony, all Form 4s, filed between Jun 16, 2025 and Sep 15, 2026. Those filings report 5 transactions, from Jun 12, 2025 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jones Keith Anthony's filings is in DURHAM, NC.
Recent filings by Jones Keith Anthony
- Sep 14, 2026: Open-market purchase of HUMA shares (Form 4, code P).
- Aug 20, 2026: Open-market purchase of HUMA shares (Form 4, code P).
- Aug 17, 2026: Open-market purchase of HUMA shares (Form 4, code P).
- Jun 11, 2026: Grant or award of HUMA derivative securities (Form 4, code A).
- Jun 12, 2025: Grant or award of HUMA derivative securities (Form 4, code A).
Other insiders filing for Humacyte, Inc. (HUMA)
- COWARD D SCOTT, Director
- Kuznik Paul Brian, Director
- Windham-Bannister Susan Richards, Director
- Constantino Michael T., Director
- Wallace Max N., Director
- Niklason Laura E, President, CEO and Director